Finward Bancorp opened lower at $43.34, compared with its previous close of $43.63. In the last trading session, the stock traded between $43.34 and $43.67. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Finward Bancorp is now worth
$ 93.20
Resulting in a loss of
$ 6.80 (6.80%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.21 (-0.48%)
Day High
$43.67
Day Low
$43.34
Day Open
$43.34
Prev Close
$43.63
Volume
10,454
1W Return
-2.72%
1M Return
4.19%
3M Return
-3.00%
6M Return
36.80%
1Y Return
25.42%
Fundamentals
Market Cap ($ Mn)
188
PE Ratio
19.10
PB Ratio
1.05
PEG Ratio
0.23
ROE
5.07%
ROCE
-
EPS (TTM)
$0.48
Investment Returns
1 Week
-2.72%
1 Month
4.19%
3 Months
-3.00%
6 Months
36.80%
9 Months
16.07%
Financials
Quarterly
All values in $ Mn
15.5
Mar 25
16.6
Jun 25
17.4
Sep 25
16.5
Dec 25
17.5
Mar 26
17.8
Jun 26
Updates
5Nov
Finward Bancorp declares $0.12 per share dividend for December 2026
Finward Bancorp declared a dividend of $0.12 per share. Payment date set for December 2, 2026. Record date is November 18, 2026. Board approved the payout on November 4, 2026.
8 days ago
14Oct
KSF investigates adequacy of Finward Bancorp sale terms to First Financial
Kahn Swick & Foti investigates the proposed sale of Finward Bancorp to First Financial Bancorp. Shareholders receive 1.35 shares of First Financial for each Finward share under the deal. The inquiry focuses on whether the price and process undervalued the company. Affected investors can contact KSF at no cost to discuss legal rights.
1mo ago
5Sep
Finward Bancorp declares $0.12 per share dividend
Finward Bancorp declared a $0.12 per share dividend. Record date is set for September 18, 2026. Payment will be made on September 25, 2026. Company holds stock of Peoples Bank.
2mo ago
30Jul
Monteverde probes fairness of Finward, Personalis, BioLife, and Utz merger deals
Monteverde & Associates PC probes the fairness of four major M&A deals: Finward Bancorp's all-stock sale to First Financial Bancorp, Personalis's acquisition by Tempus AI, BioLife Solutions's mixed-consideration sale to Repligen Corporation, and Utz Brands's cash acquisition by Intersnack Group. The firm alleges potential breaches of fiduciary duty and urges shareholders to seek legal counsel.
Finward Bancorp reported Q2 net income of $2.1M ($0.48/share), missing estimates significantly due to merger costs. Revenue rose 5.71% YoY to $17.578M but also missed forecasts. Loan growth remained strong at 3.3% quarterly.
